|
|
|
|
Efficacy and Safety of the siRNA JNJ-3989 and/or
the Capsid Assembly Modulator JNJ-6379 for the
Treatment of Chronic Hepatitis B Virus Infection :
Results From the Phase 2b REEF-1 Study
|
|
|
AASLD 2021 Nov 12-15
Man-Fung Yuen,1 Tarik Asselah,2 Ira M. Jacobson,3 Maurizia Brunetto,4 Harry L.A. Janssen,5 Tetsuo Takehara,6 Jin Lin Hou,7 Thomas N. Kakuda,8 Tom Lambrecht,8 Maria Beumont,8 Ronald Kalmeijer,8 Carine Guinard-Azadian,8 Cristiana Mayer,8 John Jezorwski,8 Thierry Verbinnen,8 Oliver Lenz,8 Umesh Shukla,8 Michael Biermer8
|
|
|
|
|
|
|